References
- Hankey GJ, Jamrozik K, Broadhurst RJ, Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke 1998;29(12):2491–500.
- Tuomilehto J, Rastenyte D, Jousilahti P, Diabetes mellitus as a risk factor for death from stroke. Prospective study of the middle-aged Finnish population. Stroke 1996; 27(2):210–5.
- Megherbi SE, Milan C, Minier D, Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke 2003; 34(3):688–94.
- Luchsinger JA, Tang MX, Stern Y, Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 2001;154(7):635–41.
- Alkan, A, Kutlu R, Hallac T, Occupational prolonged organic solvent exposure in shoemakers: brain MR spectroscopy findings. Magn Reson Imaging 2004;22(5):707–13.
- Alkan A, Kutlu R, Kocak G, Brain MR spectroscopy in children with a history of rheumatic fever with special emphasis on neuropsychiatric complications. Eur J Radiol. 2004;49(3):224–8.
- Alkan A, Sarac K, Kutlu R, Proton MR spectroscopy features of normal appearing white matter in neurofibromatosis type 1. Magn Reson Imaging 2003; 21(9):1049–53.
- Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15(7):539–53.
- Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990;21(4):637–76.
- Bitsch A, Bruhn H, Vougioukas V, Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999;20(9):1619–27.
- Cecil KM, Jones BV. Magnetic resonance spectroscopy of the pediatric brain. Top Magn Reson Imaging 2001;12(6):435–52.
- Frahm J, Bruhn H, Gyngell ML, Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn Reson Med 1989;11(1):47–63.
- Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-l-aspartate, creatine and choline. NMR Biomed 1991; 4(2):47–52.
- Higuchi T, Fernandez EJ, Maudsley AA, Mapping of lactate and N-acetyl-L-aspartate predicts infarction during acute focal ischemia: in vivo 1H magnetic resonance spectroscopy in rats. Neurosurgery 1996;38(1):121–9; discussion 129–30.
- Parsons MW, Li T, Barber PA, Combined(1)H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome. Neurology 2000;55(4):498–505.
- Kreis R, Ross BD. Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology 1992;184(1):123–30.
- Sarac K, Akinci A, Alkan A, Brain metabolite changes on proton magnetic resonance spectroscopy in children with poorly controlled type 1 diabetes mellitus. Neuroradiology 2005;47(7):562–5.
- Yip PK, He YY, Hsu CY, Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion. Neurology 1991;41(6):899–905.
- Prado R, Ginsberg MD, Dietrich WD, Hyperglycemia increases infarct size in collaterally perfused but not end-arterial vascular territories. J Cereb Blood Flow Metab 1988;8(2):186–92.
- Vincent AM, Brownlee M, Russell JW. Oxidative stress and programmed cell death in diabetic neuropathy. Ann NY Acad Sci 2002; 959:368–83.
- Kumar JS, Menon VP. Effect of diabetes on levels of lipid peroxides and glycolipids in rat brain. Metabolism 1993;42(11):1435–9.
- Kario K, Matsuo T, Hoshide S, Effect of thrombin inhibition in vascular dementia and silent cerebrovascular disease. An MR spectroscopy study. Stroke 1999;30(5):1033–7.
- Goldberg MP, Ransom BR. New light on white matter. Stroke 2003;34(2):330–2.
- Graham GD, Kalvach P, Blamire AM, Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarction. Stroke 1995;26(2):225–9.
- Gideon P, Henriksen O, Sperling B, Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke. A proton magnetic resonance spectroscopy study. Stroke 1992;23(11):1566–72.